Gina M. Wallar - 01 Mar 2022 Form 4 Insider Report for NEOGENOMICS INC (NEO)

Role
President, Pharma Services
Signature
/s/ Halley E. Gilbert, Attorney-in-Fact
Issuer symbol
NEO
Transactions as of
01 Mar 2022
Net transactions value
$0
Form type
4
Filing time
03 Mar 2022, 18:56:42 UTC
Previous filing
08 Feb 2022
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction NEO Common Stock Award $0 +11,677 +54% $0.000000 33,443 01 Mar 2022 Direct F1, F2

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction NEO Stock Option (Right to Buy) Award $0 +28,506 $0.000000 28,506 01 Mar 2022 Common Stock 28,506 $21.41 Direct F9
holding NEO Stock Option (Right to Buy) 6,667 01 Mar 2022 Common Stock 6,667 $9.22 Direct F3
holding NEO Stock Option (Right to Buy) 8,334 01 Mar 2022 Common Stock 8,334 $13.87 Direct F4
holding NEO Stock Option (Right to Buy) 7,153 01 Mar 2022 Common Stock 7,153 $20.83 Direct F5
holding NEO Stock Option (Right to Buy) 7,879 01 Mar 2022 Common Stock 7,879 $27.34 Direct F6
holding NEO Stock Option (Right to Buy) 8,595 01 Mar 2022 Common Stock 8,595 $48.99 Direct F7
holding NEO Stock Option (Right to Buy) 10,126 01 Mar 2022 Common Stock 10,126 $43.95 Direct F8
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 On March 1, 2022, Ms. Wallar was granted 11,677 restricted stock awards. These awards vest ratably over the first four anniversary dates of the grant date.
F2 This balance includes 104 shares that were acquired at a price of $19.16 per share pursuant to NeoGenomics's Employee Stock Purchase Plan (ESPP) during the month ended January 31, 2022. The shares wereacquired in transactions exempt from Section 16b-3.
F3 On April 19, 2018, Ms. Wallar was granted 20,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
F4 On December 12, 2018, Ms. Wallar was granted 25,000 stock options. The options vested ratably over the first three anniversary dates of the grant date.
F5 On May 1, 2019, Ms. Wallar was granted 9,537 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F6 On May 1, 2020, Ms. Wallar was granted 7,879 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F7 On May 1, 2021, Ms. Wallar was granted 8,595 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F8 On July 5, 2021, Ms. Wallar was granted 10,126 stock options. The options vest ratably over the first four anniversary dates of the grant date.
F9 On March 1, 2022, Ms. Wallar was granted 28,506 stock options. These options vest ratably over the first four anniversary dates of the grant date.

Remarks:

Exhibit List: Exhibit 24 - Limited Power Of Attorney